Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheraPb - [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer
NCT05720130Phase 2Recruiting
- Sponsor
- AdvanCell
- Start
- Mar 2023
- Primary completion
- Jan 2029
- Modality
- Alpha Emitters, Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ADVC001 in prostate cancer (PCa), sponsored by AdvanCell. Started Mar 2023; status: recruiting.
02
Drugs
ADVC001
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05720130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05720130.